| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 17, 2025 | Option exercise(M) | 6K | — | $0 | 50K |
| Mar 17, 2025 | Tax withholding(F) | 2K | $15.91 | $30K | 48K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 17, 2025 | Option exercise(M) | 6K | — | $0 | 13K |
| Mar 14, 2025 | Grant(A) | 14K | — | $0 | 14K |
| Mar 14, 2025 | Grant(A) | 28K | — | $0 | 28K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-001532) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Anika Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001171843-25-001532"
Use Arkolith to summarize insider buying and selling at Anika Therapeutics, Inc. over the last 90 days and cite the filings.